Back to ARNA Stock Lookup

Arena Pharma (ARNA) – Company Press Releases

Jan 21, 2015 08:45 AM Arena Pharmaceuticals Announces Agreement to Sell Common Stock
Jan 20, 2015 04:04 PM Arena Pharmaceuticals Announces Public Offering of Common Stock
Jan 12, 2015 08:00 AM Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension
Jan 9, 2015 08:00 AM Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV
Jan 7, 2015 08:00 AM Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases
Jan 6, 2015 08:00 AM Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Nov 25, 2014 08:00 AM Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds
Nov 24, 2014 08:00 AM Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
Nov 13, 2014 08:00 AM Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference
Nov 6, 2014 08:00 AM Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases
Nov 5, 2014 08:00 AM Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
Nov 3, 2014 06:45 AM Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Nov 3, 2014 06:30 AM Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation
Oct 31, 2014 08:00 AM Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting

Back to ARNA Stock Lookup